A blood pressure drug was discovered while searching for a malaria cure
In short: Hydralazine, a medicine for high blood pressure and heart failure, owes its origin to a different goal entirely. Chemists at the company Ciba were hunting for a malaria treatment when they noticed its blood-pressure-lowering effect. Decades later it still appears on the World Health Organization's roster of essential medicines.
Hydralazine is marketed under the brand name Apresoline, among others. It treats high blood pressure, including readings that rise during pregnancy and very high readings that cause symptoms, and it is also used in heart failure. It can be taken by mouth or given by injection into a vein, and its effects typically begin about 15 minutes after dosing and can last up to six hours. It belongs to the vasodilator family, drugs believed to work by widening blood vessels.
The drug's discovery is a useful story about serendipity. Ciba's researchers were searching for antimalarial compounds, and their patent application was lodged in 1945 and granted in 1949. The first scientific papers describing its blood-pressure effects appeared in 1950, and the US regulator approved it in 1953. It was also among the first antihypertensive medicines that patients could take orally. Recent figures place it 109th among the most frequently prescribed drugs in America, with a prescription count above six million.
Hydralazine is not a first-line treatment for everyday high blood pressure. Its precise mechanism is not fully understood: it relaxes smooth muscle in small resistance arteries, and as of 1981 the exact mechanism was still unclear. Because it triggers a reflex that speeds up the heart, it is usually combined with a beta blocker such as propranolol and a diuretic. It is not recommended for people with coronary artery disease, and common side effects include headache and a fast heart rate.
Its most notable modern use pairs hydralazine with isosorbide dinitrate for heart failure in Black patients, a combination that became the first race-based prescription drug. Prolonged treatment can also cause a lupus-like syndrome that may become fatal if it goes unnoticed and the drug is stopped, and hydralazine is counted among the top three drugs known to induce lupus. Researchers have additionally studied it as a possible treatment for myelodysplastic syndrome.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Hydralazine
To cite this card, link to https://intellectplus.co.uk/app/health-hydralazine.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Medicines · More in Health · Latest · A–Z · All topics